FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/17/2025
Back to search
Official data from USPTO
CELLUSION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELLUSION
ST13
US500000079359284Class
42, 44
Filing
79359284
Registration
7349557
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
01/17/2025
Trademark type
Word
Nice classes
42, 44
Filing date
08/03/2022
Registration date
04/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2024
Last transaction
01/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
BLOHM, LINDA
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cellusion Inc.
Representatives
Holly M. Ford Lewis Oliff PLC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Testinginspection and research of pharmaceuticals and consultancy relating thereto; research and development of pharmaceuticals and medical supplies; clinical trials; medical research; biological research; providing information relating to research of medicine; providing information relating to testinginspection or research of medical services using of stem cells; providing information relating to research and development of pharmaceutical preparations; pharmaceutical drug development services; culturing of cells for scientific research purposes; testinginspection or research of medical treatment methods and techniques; testinginspection or research of cosmetics or foodstuffs; scientific research in the field of genetic engineering; scientific services relating to the isolation and cultivation of human tissues and cells; stem cell research services; research and development services in the field of gene expression systems; testinginspection or research of regenerative medicine services; testinginspection or research in the field of cells; culturing of cells for others for scientific research purposes; genetic testing of cells for research purposes; culturing cells for transplantation collected from patients themselves; providing quality assurance services in the field of therapeutic compositionscompositions containing cells for regenerative medicine servicesgene therapyviruses; quality assurance consultancy services in the field of therapeutic compositionscompositions containing cells for regenerative medicine servicesgene therapyviruses; quality control of goods and services of others; consultancy services relating to quality control of goods and services of others
Class 44
Providing medical information; medical and veterinary information services provided via the Internet; providing information to patients in the field of administering medication; medical care and analysis services relating to patient treatment; health clinic services; collectionanalysisprovision of information relating to medical care; treatment or diagnosis using regenerative medicine services; treatment or diagnosis using cell medicine services; dietary and nutritional guidance; animal breeding; veterinary services; rental of medical apparatus and instruments; providing medical or pharmaceutical consultancy and information services relating to biopharmaceutical products; cultured cell bank services for medical transplantation; medical treatment using cultured cells; stem cell bank services; stem cell therapy services; providing medical information in the field of cells; providing medical information in the field of regenerative medicine services; collection and preservation of biological tissuesblood and cells; treatment and diagnosis performed by culturing medical or clinical cells; medical services; providing information and data for diagnosis and medical treatment; medical treatment with cell preparations; medical professional consulting services; preservation of human blood for use as a source of stem cells; genetic testing for medical purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; health center services
Publications
History of USPTO decisions and trademark events.
27 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/31/2024
FIMP
FINAL DISPOSITION PROCESSED
12/31/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/19/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/09/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/23/2024
PUBO
PUBLISHED FOR OPPOSITION
01/23/2024
GPNX
NOTIFICATION PROCESSED BY IB
01/22/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/03/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/18/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/13/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/13/2023
RFNP
REFUSAL PROCESSED BY IB
07/26/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/06/2023
RFRR
REFUSAL PROCESSED BY MPU
07/05/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/23/2023
CNRT
NON-FINAL ACTION WRITTEN
05/22/2023
DOCK
ASSIGNED TO EXAMINER
05/22/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/10/2023
MAFR
APPLICATION FILING RECEIPT MAILED
01/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/30/2022
Continuous trademark protection
Get notified about every new filing that threatens CELLUSION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.